SCHEMBL1635263

SCHEMBL1635263

COc1ccc(CBr)cc1SP(=O)(O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.36
CA2 P00918 4/20 0.36
ALDH1A1 P00352 1/20 0.36
LDHA P00338 1/20 0.36
GAA P10253 1/20 0.36
CA1 P00915 3/20 0.34
CA9 Q16790 3/20 0.34
CA12 O43570 2/20 0.34
ALOX15 P16050 2/20 0.34
SMPD1 P17405 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PKM P14618 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
KMT2A Q03164 1/20 0.33
ALOX12 P18054 1/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634734 0.85 TTR (0.43) CA2ALDH1A1LDHAGAAALOX15
SCHEMBL1634215 0.85 IDO1 (0.37) CA2ALDH1A1LDHAGAAALOX15
SCHEMBL1635201 0.75 GAA (0.37) CA2ALDH1A1LDHAGAACA1
SCHEMBL1634468 0.75 INPPL1 (0.47) ACHECA2ALDH1A1LDHACA1
SCHEMBL1635298 0.72 PLK1 (0.58) SMN1; SMN2CYP1A2
SCHEMBL29559892 0.70 CA2 (0.68) CA2ALDH1A1LDHACA1CA9
SCHEMBL1080853 0.70 CA2 (0.68) CA2ALDH1A1LDHACA1CA9
SCHEMBL1635474 0.70 IDO1 (0.37) CA2ALDH1A1LDHAGAASMN1; SMN2
SCHEMBL1635174 0.70 PDE4A (0.54) ALDH1A1GAASMN1; SMN2L3MBTL1KMT2A
SCHEMBL6401380 0.70 CYP1A2 (0.62) GAAALOX15CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 ACHE 4839/4885CA2 4289/4885ALDH1A1 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.